 
2英文摘要
Keywords : cancer, oncogene, gene regulation network, transcriptional regulation, microRNA,
Oncomine database, GEO database, Array-Express database, regulation module
Cancer is extraordinary gene regulation over cellular cycle that presents abnormal cell
growth and division. It is caused by a series of gene mutations in cellular genome. There are a
variety of ways that cellular genome could become disorder. For example, environmental factors
can bring the defects in cellular genome that lead to cancer. The genes is termed as oncogene
when its mutations help turn a normal cell into cancer cell. Most oncogenes require additional
mutations in other genes, or environmental factors, such as viral infection, to cause cancer.
These genes are usually taken as markers in cancer diagnosis. Cancer is a serious and potentially
vital illness. There are multiple types of cancer, many of which can be effectively treated today
as to reduce or slow the evolution of the disease. To understand the functions and regulation
relations regarding oncognes are critical in deciphering the mechanism of carcinogenesis. It is
important in the selection of treatment strategy and drug discovery for cancer. In recent years,
microarray technology was effectively applied to discover oncogenes via expression differential
experiments of tumor vs. normal cell. In advance, a systematic method is needed to analysis the
correlations and regulations regarding these genes. As contrasted to basic correlations analyses,
gene regulation network offer the ability to resolve causality by elucidating the directional
linkages between genes in the biological system.
This project was focused on the discovery of the cancer related biological networks based
on microarray data. The microarray data of normal vs. tumor experiments were extracted from
Oncomine database.
4研究目的與文獻探討
Introduction
Cancer is extraordinary gene regulation over cellular cycle that presents abnormal cell
growth and division. It is caused by a series of gene mutations in cellular genome. There are a
variety of ways that cellular genome could become disorder. For example, environmental factors
can bring the defects in cellular genome that lead to cancer. The genes is termed as oncogene
when its mutations help turn a normal cell into cancer cell. Most oncogenes require additional
mutations in other genes, or environmental factors, such as viral infection, to cause cancer. All
these genes are usually taken as markers in cancer diagnosis. Cancer is a serious and potentially
vital illness. There are multiple types of cancer, many of which can be effectively treated today as
to reduce or slow the evolution of the disease. To understand the functions and regulation
relations regarding oncognes are critical in deciphering the mechanism of carcinogenesis. It is
important in the selection of treatment strategy and drug discovery for cancer. In recent years,
microarray technology was effectively applied to discover oncogenes via expression differential
experiments of tumor vs. normal cell. In advance, a systematic method is needed to analysis the
correlations and regulations regarding these genes. As contrasted to basic correlations analyses,
gene regulation network offer the ability to resolve the mechanism of carcinogenesis by
elucidating the directional linkages between genes in the biological system.
The Human Gene Regulation Network
There are two types of gene regulatory relation will be considered here, one is
transcriptional regulation defined by the transcription factor (TF) binding events on the promoter
region of genes, another is the degradation of mRNA bring by microRNA binding. The
complexity of regulation machinery makes elucidation of regulatory networks a very difficult
task. In recent years, the combination of chromatin immunoprecipitation (ChIP) with promoter
DNA microarrays (ChIP-on-chip) have applied substantially to the elucidation of transcriptional
regulatory networks, which crucially contributed to identify direct target genes under a given TF.
TRANSFAC is a database contains these information cover the range of species from yeast to
human (Wingender, 2008). Although the data content in TRANSFAC is abundant, but it covered
only a little part of overall gene regulatory network for human. Fortunately, there are many
algorithms have developed to the prediction of transcriptional regulations over the years. Most of
them were based on the sequence motif of the binding sites extracted from orthologs genes across
different species. The characters of sequence motif were incorporated with position weight
matrices (Stormo, 2000), text mining (Neduva et al., 2005), or support vector machines (Martin
et al., 2005) to predict the TF binding sites for unknown genomic sequences. Numerical
simulation for microarray time series data was also frequently used to reveal regulatory networks
with a limited number of genes (Vu and Vohradsky, 2007; Hughes et al., 2000; Beal et al., 2005).
It was shown to capture the behavior of transcriptional regulation with good accuracy for small
regulatory networks. Recently, Several approaches, including GRAM (Bar-Joseph et al., 2003),
COGRIM (Chen et al., 2007), ReMoDiscovery (Lemmens et al. 2007), and AdaFuzzy (Chuang et
al., 2009) have been proposed to infer transcriptional regulatory relations using both DNA
6al., 2009).
The Oncomine database (Rhodes et al., 2007) consists of three layers: data input, data
analysis, and data visualization (Figure 1). The data input layer has two components:
microarray data pipeline and annotation data repository. The microarray pipeline collect
microarray studies from published literature and provides tools for data analysis in advance. To
date, there are 264 independent data sets, totaling > 18,000 microarray experiments, which span
35 cancer types and 143 cancer subtypes. The PubMed citations are available for its related
studies. The annotation repository integrated the gene information from14 external databases
(Table 1) to interpret the role of individual genes in cancer and for filtering cancer signatures. The
data analysis layer consists of microarray data standardization and automated statistical analysis.
Automated statistical analysis component provides analysis modules for performing logical
differential expression analyses, cluster analyses, and gene set enrichment analyses etc. Lastly,
the Oncomine web layer queries data from the Oncomine database and displays the results with
tabular and graphical representations online. The web layer is implemented in Java/JSP platform.
Figure 1. (Rhodes et al., 2007)
Table 1. (Rhodes et al., 2007)
8研究方法
METHODOLOGY
In this project, we explore cancer related gene networks by microarray data analysis. The
research schedule is depicted in Figure 2 and described as follows.
Figure 2.
Section One
In this section, we attempt to discover the cancer related gene networks based on the each
type of biological network. The microarray data from expression differential experiments of
tumor vs. normal cell is extracted from Oncomine database, GEO database, and Array-Express
database (Chung et al., 2002; Parkinson et al., 2005; Rhodes et al., 2007). The t-statistics is used
to define the expression differential genes including over expression and under expression with
p=0.01 statistical significance. The classification of caner subtypes, according to the catalog of
Oncomine database, is listed as follows:
# Type Subtype Platform Reference
1 Bladder Cancer
Infiltrating Bladder Urothelial
Carcinoma Human Genome U133AArray Dyrskjot et al.
Stage 0is Bladder Urothelial Carcinoma Human Genome U133AArray Dyrskjot et al.
Superficial Bladder Cancer Human Genome U133AArray Dyrskjot et al.
2 Brain and CNS Cancer
Anaplastic Astrocytoma Human Genome U133 Plus 2.0 Array Sun et al.
Anaplastic Oligoastrocytoma Human Genome U133 Plus 2.0 Array French et al.
Anaplastic Oligodendroglioma Human Genome U133 Plus 2.0 Array French et al.
Astrocytoma Human Genome U95A-Av2 Array Shai et al.
Atypical Teratoid/Rhabdoid Tumor HumanGeneFL Array Pomeroy et al.
Classic Medulloblastoma HumanGeneFL Array Pomeroy et al.
Desmoplastic Medulloblastoma HumanGeneFL Array Pomeroy et al.
Diffuse Astrocytoma Human Genome U133 Plus 2.0 Array Sun et al.
Glioblastoma Human Genome U133 Plus 2.0 Array Lee et al.
Meningioma Human Cancer Biology Array Watson et al.
Oligoastrocytoma Liang Liang et al.
10
Thyroid Gland Carcinoma Human Genome U95A-Av2 Array Huang et al.
Tongue Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al.
Tongue Squamous Cell Carcinoma Human Genome U133 Plus 2.0 Array Ye et al.
Tonsillar Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al.
7 Kidney Cancer
Chromophobe Renal Cell Carcinoma Human Genome U133 Plus 2.0 Array Yusenko et al.
Clear Cell Renal Cell Carcinoma Human Genome U133 Plus 2.0 Array Yusenko et al.
Clear Cell Sarcoma of the Kidney Human Genome U133AArray Cutcliffe et al.
Granular Renal Cell Carcinoma Higgins Higgins et al.
Hereditary Clear Cell Renal Cell
Carcinoma Human Genome U133AArray Beroukhim et al.
Non-Hereditary Clear Cell Renal Cell
Carcinoma Human Genome U133AArray Beroukhim et al.
Papillary Renal Cell Carcinoma Human Genome U133 Plus 2.0 Array Yusenko et al.
Renal Wilms Tumor Human Genome U133 Plus 2.0 Array Yusenko et al.
8 Leukemia
Acute Adult T-Cell
Leukemia/Lymphoma Human Genome U133AArray Choi et al.
Acute Myeloid Leukemia Human Genome U133AArray Valk et al.
B-Cell Acute Lymphoblastic Leukemia Andersson Andersson et al.
Chronic Adult T-Cell
Leukemia/Lymphoma Human Genome U133AArray Choi et al.
Chronic Lymphocytic Leukemia Human Genome U95A-Av2 Array Haslinger et al.
Hairy Cell Leukemia Human Genome U95A-Av2 Array Basso et al.
T-Cell Acute Lymphoblastic Leukemia Andersson Andersson et al.
T-Cell Prolymphocytic Leukemia Human Genome U133AArray Durig et al.
9 Liver Cancer
Cirrhosis Human Genome U133 Plus 2.0 Array Wurmbach et al.
Focal Nodular Hyperplasia of the Liver Chen Chen et al.
Hepatocellular Adenoma Chen Chen et al.
Hepatocellular Carcinoma Human Genome U133 Plus 2.0 Array Wurmbach et al.
Liver Cell Dysplasia Human Genome U133 Plus 2.0 Array Wurmbach et al.
10 Lung Cancer
Large Cell Lung Carcinoma Garber Garber et al.
Lung Adenocarcinoma Human Genome U133AArray Su et al.
Lung Carcinoid Tumor Human Genome U95A-Av2 Array Bhattacharjee et al.
Small Cell Lung Carcinoma Garber Garber et al.
Squamous Cell Lung Carcinoma Garber Garber et al.
11 Lymphoma
Activated B-Cell-Like Diffuse Large
B-Cell Lymphoma Alizadeh Alizadeh et al.
Burkitt's Lymphoma Human Genome U95A-Av2 Array Basso et al.
Centroblastic Lymphoma Human Genome U95A-Av2 Array Basso et al.
Cutaneous Follicular Lymphoma Storz Storz et al.
Diffuse Large B-Cell Lymphoma Human Genome U95A-Av2 Array Basso et al.
12
Pancreatic Intraepithelial Neoplasia Buchholz Pancreas Buchholz et al.
Pancreatitis HumanGeneFL Array Logsdon et al.
16 Prostate Cancer
Benign Prostatic Hyperplasia Tomlins Tomlins et al.
Prostate Adenocarcinoma
Human Genome U133AArray/Human
Genome U133B Array Vanaja et al.
Prostate Carcinoma Human Genome U133 Plus 2.0 Array Varambally et al.
Prostatic Intraepithelial Neoplasia Tomlins Tomlins et al.
17 Sarcoma
Dedifferentiated Liposarcoma Human Genome U133AArray Detwiller et al.
Fibrosarcoma Human Genome U133AArray Detwiller et al.
Leiomyosarcoma Human Genome U133AArray Detwiller et al.
Malignant Fibrous Histiocytoma Human Genome U133AArray Detwiller et al.
Pleomorphic Liposarcoma Human Genome U133AArray Detwiller et al.
Round Cell Liposarcoma Human Genome U133AArray Detwiller et al.
Synovial Sarcoma Human Genome U133AArray Detwiller et al.
Uterine Corpus Leiomyosarcoma HumanGeneFL Array Quade et al.
Section Two
In this section, we adopt enrichment analysis and Network Analysis Tools (NeAT) to mine
the cancer related gene networks. NeAT (Brohe´e et al., 2008) is a package of network tools that
integrate various computational modules for the analysis of biological networks, such as
comparison between graphs, between clusters, or between graphs and clusters; network
randomization; analysis of degree distribution; network-based clustering and path finding. In
these modules, the module graph-topology can be used to analyze the degree distribution of any
kind of biological network. The module compare-graphs which computes the intersection
between two networks and estimates the statistical significance of the overlap with enrichment
analysis. The tool graph-neighbours which calculates the neighbors of a query node in a network
for a certain distance. The cluster analysis module integrated many algorithm and the resulting
subnetworks can be compared to some reference groups (e.g., functional classes) with the module
compare-classes. This function is important for the deciphering of cancer related regulation
modules. The path finding module can find a biological meaningful path connecting two nodes of
interest for a given biological network.
14
Fibroadenoma 2 0 1
Invasive Breast Carcinoma 0 0 0
Invasive Lobular Breast Carcinoma 4 2 2
Invasive Mixed Breast Carcinoma 2 0 3
Lobular Breast Carcinoma 5 2 2
4 Cervical Cancer
5 Gastrointestinal Cancer
Barrett's Esophagus 2 0 1
Cecum Adenocarcinoma 4 0 1
Colon Adenocarcinoma 10 4 2
Colon Adenoma 1 0 3
Colon Carcinoma 4 0 0
Colon Mucinous Adenocarcinoma 7 0 1
Colorectal Adenoma 0 0 0
Colorectal Carcinoma 1 4 3
Diffuse Gastric Adenocarcinoma 6 0 2
Esophageal Adenocarcinoma 5 1 1
Gastric Intestinal Type Adenocarcinoma 9 3 1
Gastric Mixed Adenocarcinoma 5 3 1
Rectal Adenocarcinoma 12 4 2
Rectal Adenoma 0 0 0
Rectal Mucinous Adenocarcinoma 1 0 0
Rectosigmoid Adenocarcinoma 10 1 0
6 Head and Neck Cancer
Floor of the Mouth Carcinoma 3 1 0
Head and Neck Squamous Cell
Carcinoma
8 4 7
Hypopharyngeal Squamous Cell
Carcinoma
6 1 2
Oral Cavity Carcinoma 1 2 1
Oral Cavity Squamous Cell Carcinoma 1 0 1
Oropharyngeal Carcinoma 2 4 0
Salivary Gland Adenoid Cystic
Carcinoma
4 0 0
Thyroid Gland Carcinoma 5 3 0
Tongue Carcinoma 3 7 2
Tongue Squamous Cell Carcinoma 10 1 5
Tonsillar Carcinoma 5 1 0
7 Kidney Cancer
Chromophobe Renal Cell Carcinoma 4 0 0
Clear Cell Renal Cell Carcinoma 17 5 0
Clear Cell Sarcoma of the Kidney 2 1 3
16
12 Melanoma
Benign Melanocytic Skin Nevus 2 0 1
Cutaneous Melanoma 8 0 3
Non-Neoplastic Nevus 4 1 1
13 Myeloma
Monoclonal Gammopathy of
Undetermined Significance
3 0 3
Multiple Myeloma 16 4 7
Smoldering Myeloma 2 0 0
14 Ovarian Cancer
Ovarian Adenocarcinoma 1 1 0
Ovarian Clear Cell Adenocarcinoma 4 1 2
Ovarian Endometrioid Adenocarcinoma 0 0 0
Ovarian Mucinous Adenocarcinoma 7 1 0
Ovarian Serous Adenocarcinoma 8 0 1
Ovarian Serous Cystadenocarcinoma 6 5 1
15 Pancreatic Cancer
Pancreatic Adenocarcinoma 12 1 1
Pancreatic Carcinoma 3 0 0
Pancreatic Ductal Adenocarcinoma 3 2 0
Pancreatic Intraepithelial Neoplasia 9 0 1
Pancreatitis 1 0 2
16 Prostate Cancer
Benign Prostatic Hyperplasia 11 2 7
Prostate Adenocarcinoma 4 3 2
Prostate Carcinoma 21 2 1
Prostatic Intraepithelial Neoplasia 3 0 1
17 Sarcoma
Dedifferentiated Liposarcoma 11 0 0
Fibrosarcoma 7 4 7
Leiomyosarcoma 5 3 8
Malignant Fibrous Histiocytoma 5 2 6
Pleomorphic Liposarcoma 7 0 4
Round Cell Liposarcoma 4 1 1
Synovial Sarcoma 4 0 1
Uterine Corpus Leiomyosarcoma 2 0 5
18
Cutcliffe, C., Kersey, D., Huang, C.C., Zeng, Y., Walterhouse, D., and Perlman, E.J. (2005) Clear cell sarcoma of
the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer
Res., 11, 7986-7994.
Dürig, J., Bug, S., Klein-Hitpass, L., Boes, T., Jöns, T., Martin-Subero, J.I., Harder, L., Baudis, M., Dührsen, U.,
and Siebert, R. (2007) Combined single nucleotide polymorphism-based genomic mapping and global gene
expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the
pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia, 21, 2153-2163.
Dyrskjøt, L., Kruhøffer, M., Thykjaer, T., Marcussen, N., Jensen, J.L., Møller, K., and Ørntoft, T.F. (2004) Gene
expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding
histopathological classification. Cancer Res., 64, 4040-4048.
Elfilali, A., Lair, S., Verbeke, C., La Rosa, P., Radvanyi, F. and Barillot, E. (2006) ITTACA: a new database for
integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res., 34, D613–D616.
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian,
S., Omeroglu, A., Hallett, M., and Park, M. (2008) Stromal gene expression predicts clinical outcome in breast cancer.
Nat Med., 14, 518-527.
French, P.J., Swagemakers, S.M., Nagel, J.H., Kouwenhoven, M.C., Brouwer, E., van der Spek, P., Luider, T,M,,
Kros, J.M., van den Bent, M.J., and Sillevis Smitt, P.A. (2005) Gene expression profiles associated with treatment
response in oligodendrogliomas. Cancer Res., 65, 11335-11344.
Frierson, H.F., Jr, El-Naggar, A.K., Welsh, J.B., Sapinoso, L.M., Su, A.I., Cheng, J., Saku, T., Moskaluk, C.A.,
Hampton, G.M. (2002) Large scale molecular analysis identifies genes with altered expression in salivary adenoid
cystic carcinoma. Am J Pathol., 161, 1315-1323.
Garber, M.E., Troyanskaya, O.G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn,
M., Rosen, G.D., Perou, C.M., Whyte, R.I., Altman, R.B., Brown, P.O., Botstein, D., and Petersen, I. (2001) Diversity
of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A, 98, 13784-13789.
Gaspar, C., Cardoso, J., Franken, P., Molenaar, L., Morreau, H., Möslein, G., Sampson, J., Boer, J.M., de Menezes,
R.X., and Fodde, R. (2008) Cross-species comparison of human and mouse intestinal polyps reveals conserved
mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am J Pathol., 172, 1363-80.
Ginos, M.A., Page, G.P., Michalowicz, B.S., Patel, K.J., Volker, S.E., Pambuccian, S.E., Ondrey, F.G., Adams, G.L.,
and Gaffney, P.M. (2004) Identification of a gene expression signature associated with recurrent disease in squamous
cell carcinoma of the head and neck. Cancer Res., 64, 55-63.
Graudens, E., Boulanger, V., Mollard, C., Mariage-Samson, R., Barlet, X., Grémy, G., Couillault, C., Lajémi, M.,
Piatier-Tonneau, D., Zaborski, P., Eveno, E., Auffray, C., and Imbeaud, S. (2006) Deciphering cellular states of innate
tumor drug responses. Genome Biol., 7, R19.
Gutmann, D.H., Hedrick, N.M., Li, J., Nagarajan, R., Perry, A., and Watson, M.A. (2002) Comparative gene
expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res., 62,
2085-2091.
Guelzim, N., Bottani, S., Bourgine, P., and Kepes, F. (2002) Topological and causal structure of the yeast
transcriptional regulatory network. Nat Genet., 31, 60-63.
Hughes, T. et al. (2000) Functional discovery via a compendium of expression profiles. Cell, 102, 109–126.
Hao, Y., Triadafilopoulos, G., Sahbaie, P., Young, H.S., Omary, M.B., and Lowe, A.W. (2006) Gene expression
profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
Gastroenterology, 131, 925-933.
20
Mangan, S., Zaslaver, A., and Alon, U. (2003) The coherent feedforward loop serves as a sign-sensitive delay
element in transcription networks. J Mol Biol., 334, 197-204.
Maragkakis, M., Alexiou, P., Papadopoulos, L.G., Reczko, M., Simossis, A.V., Riback, M., Kourtis, K., Goumas,
G., Koukis, K., Dalamagas, T., et al. (2009) DIANA-MicroT 3.0: An integrative function analysis tool for
microRNAs. Nucleic Acids Res., 37, W273-6.
Martin, S. et al. (2005) Predicting protein–protein interactions using signatureproducts. Bioinformatics, 21,
218–226.Neduva, V. et al. (2005) Systematic discovery of new recognition peptides mediating protein interaction
networks. PLoS Biol. , 3, e405.
Parkinson, H., Sarkans, U., Shojatalab, M., Abeygunawardena, N., Contrino, S., Coulson, R., Farne, A., Lara, G.G.,
Holloway, E., Kapushesky, M., et al. (2005). ArrayExpress—a public repository for microarray gene expression data
at the EBI. Nucleic Acids Res., 33, D553–D555.
Pomeroy, S.L., Tamayo, P., Gaasenbeek, M., Sturla, L.M., Angelo, M., McLaughlin, M.E., Kim, J.Y., Goumnerova,
L.C., Black, P.M., Lau, C., Allen, J.C., Zagzag, D., Olson, J.M., Curran, T., Wetmore, C., Biegel, J.A., Poggio, T.,
Mukherjee, S., Rifkin, R., Califano, A., Stolovitzky, G., Louis, D.N., Mesirov, J.P., Lander, E.S., and Golub, T.R.
(2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature, 415,
436-442.
Pyeon, D., Newton, M.A., Lambert, P.F., den Boon, J.A., Sengupta, S., Marsit, C.J., Woodworth, C.D., Connor,
J.P., Haugen, T.H., Smith, E.M., Kelsey, K.T., Turek, L.P., and Ahlquist, P. (2007) Fundamental differences in cell
cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical
cancers. Cancer Res., 67, 4605-4619.
Radvanyi, L., Singh-Sandhu, D., Gallichan, S., Lovitt, C., Pedyczak, A., Mallo, G., Gish, K., Kwok, K., Hanna, W.,
Zubovits, J., Armes, J., Venter, D., Hakimi, J., Shortreed, J., Donovan, M., Parrington, M., Dunn, P., Oomen, R.,
Tartaglia, J., and Berinstein, N.L. (2005) The gene associated with trichorhinophalangeal syndrome in humans is
overexpressed in breast cancer. Proc Natl Acad Sci U S A, 102, 11005-11010.
Rehmsmeier, M., Steffen, P., Hochsmann, M., and Giegerich, R. (2004) Fast and effective prediction of
microRNA/target duplexes. RNA, 10, 1507-1517.
Rhodes, D.R., Kalyana-Sundaram, S., Mahavisno, V., Varambally, R., Yu, J., Briggs, B.B., Barrette, T.R., Anstet,
M.J., Kincead-Beal, C., Kulkarni, P., Varambally, V., Ghoshy, D., and Chinnaiyan, A.M. (2007) Oncomine 3.0: Genes,
Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles, Neoplasia, 9, 166–180
Richardson, A.L., Wang, Z.C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J.D., Livingston,
D.M., and Ganesan, S. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell, 9,
121-132.
Riker, A.I., Enkemann, S.A., Fodstad, O., Liu, S., Ren, S., Morris, C., Xi, Y., Howell, P., Metge, B., Samant, R.S.,
Shevde, L.A., Li, W., Eschrich, S., Daud, A., Ju, J., and Matta, J. (2008) The gene expression profiles of primary and
metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics, 28, 1-13.
Sabates-Bellver, J., Van der Flier, L.G., de Palo, M., Cattaneo, E., Maake, C., Rehrauer, H., Laczko, E., Kurowski,
M.A., Bujnicki, J.M., Menigatti, M., Luz, J., Ranalli, T.V., Gomes, V., Pastorelli, A., Faggiani, R., Anti, M., Jiricny, J.,
Clevers, H., and Marra, G. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res., 5,
1263-1275.
Schafer, J. and Strimmer, K. (2005) An empirical Bayes approach to inferring large-scale gene association
networks. Bioinformatics, 21, 754–764.
Schlingemann, J., Habtemichael, N., Ittrich, C., Toedt, G., Kramer, H., Hambek, M., Knecht, R., Lichter, P., Stauber,
22
oligonucleotide microarrays. Am J Pathol., 161, 665-672.
Wingender, E. (2008) The TRANSFAC project as an example of framework technology that supports the analysis
of genomic regulation. Brief Bioinform., 9, 326-332.
Wurmbach, E., Chen, Y.B., Khitrov, G., Zhang, W., Roayaie, S., Schwartz, M., Fiel, I., Thung, S., Mazzaferro, V.,
Bruix, J., Bottinger, E., Friedman, S., Waxman, S., and Llovet, J.M. (2007) Genome-wide molecular profiles of
HCV-induced dysplasia and hepatocellular carcinoma. Hepatology, 45, 938-947.
Ye, H., Yu, T., Temam, S., Ziober, B.L., Wang, J., Schwartz, J.L., Mao, L., Wong, D.T., and Zhou, X. (2008)
Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics, 6, 69.
Yusenko, M.V., Kuiper, R.P., Boethe, T., Ljungberg, B., van Kessel, A.G., and Kovacs, G. (2009) High-resolution
DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal
oncocytomas. BMC Cancer, 9, 152.
Yu, H., Luscombe, N.M., Qian, J., and Gerstein, M. (2003) Genomic analysis of gene expression relationships in
transcriptional regulatory networks. Trends Genet., 19:422-427.
Zhan, F., Barlogie, B., Arzoumanian, V., Huang, Y., Williams, D.R., Hollmig, K., Pineda-Roman, M., Tricot, G.,
van Rhee, F., Zangari, M., Dhodapkar, M., and Shaughnessy, J.D. (2007) Gene-expression signature of benign
monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood, 109, 1692-1700.
Zhao, H., Langerød, A., Ji, Y., Nowels, K.W., Nesland, J.M., Tibshirani, R., Bukholm, I.K., Kåresen, R., Botstein,
D., Børresen-Dale, A.L., and Jeffrey, S.S. (2004) Different gene expression patterns in invasive lobular and ductal
carcinomas of the breast. Mol Biol Cell, 15, 2523-2536.
Zou, T.T., Selaru, F.M., Xu, Y., Shustova, V., Yin, J., Mori, Y., Shibata, D., Sato, F., Wang, S., Olaru, A., Deacu, E.,
Liu, T.C., Abraham, J.M., and Meltzer, S.J. (2002) Application of cDNA microarrays to generate a molecular
taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene, 21, 4855-4862.
參加國際會議心得
國際會議一
會議名稱：International Conference on 2011 Machine Learning and Cybernetics
(ICMLC2011)
會議地點：中國桂林
會議時間：10-13 July 2011
論文名稱：Theoretical Assessment of Immunogenicity Variation on The HA Protein
of H2N2 Influenza Virus by Using Fuzzy Integral and SVM Classifier
會議重點：
參加此次國際會議的各校老師與學生頗多，因此循往例組成旅行團，於會議
正式開始前抵達桂林，桂林山多但是都不大，在前往飯店的道路兩旁接連聳立，
與印象中的中國水墨山水畫，意境相似，沒有親身去過，還真會懷疑中國水墨山
水畫中的山不切實際，如今得以證實。桂林氣候宜人，空氣清新，環境幽雅，交
通方便，在桂林的這幾天，我特意前往李宗仁故居一遊，感受歷史名人的生活環
境，桂林是個養生的好地方。
本次會議發表之論文，主要是利用我們發展出來的預測免疫性的方法，來評
估 H2N2流感病毒的 HA蛋白，在過去二十年的免疫特性變化，根據近來的研究
報告，H2N2 最有可能再引起人類的感染爆發，並造成嚴重病情，因此，瞭解
HA蛋白的免疫特性的變化，可以提早發現人類的免疫漏洞在那裡。我們的結論
是；MHC I的免疫反應在這二十年間，並沒有明顯減弱，但是，MHC II的免疫
反應在這二十年間有減弱的傾向，這意味著人類免疫系統在 MHC II 的反應路
徑，對於 H2N2的 HA蛋白，越來越沒有反應。
國科會補助計畫衍生研發成果推廣資料表
日期:2011/10/29
國科會補助計畫
計畫名稱: 從微陣列資料探勘癌症相關基因網路
計畫主持人: 張培均
計畫編號: 99-2221-E-468-010- 學門領域: 生物資訊
無研發成果推廣資料
其他成果 
(無法以量化表達之成
果如辦理學術活動、獲
得獎項、重要國際合
作、研究成果國際影響
力及其他協助產業技
術發展之具體效益事
項等，請以文字敘述填
列。) 
無 
 成果項目 量化 名稱或內容性質簡述 
測驗工具(含質性與量性) 0  
課程/模組 0  
電腦及網路系統或工具 0  
教材 0  
舉辦之活動/競賽 0  
研討會/工作坊 0  
電子報、網站 0  
科 
教 
處 
計 
畫 
加 
填 
項 
目 計畫成果推廣之參與（閱聽）人數 0  
 
